These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 11950913

  • 1. Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections.
    Moritani S, Kushima R, Sugihara H, Bamba M, Kobayashi TK, Hattori T.
    Mod Pathol; 2002 Apr; 15(4):397-405. PubMed ID: 11950913
    [Abstract] [Full Text] [Related]

  • 2. Dual usages of single Wilms' tumor 1 immunohistochemistry in evaluation of breast tumors: a preliminary study of 30 cases.
    Li JH, Man YG.
    Cancer Biomark; 2009 Apr; 5(3):109-16. PubMed ID: 19407365
    [Abstract] [Full Text] [Related]

  • 3. Papillary neoplasia of the breast: immunohistochemically defined myoepithelial cells in the diagnosis of benign and malignant papillary breast neoplasms.
    Raju UB, Lee MW, Zarbo RJ, Crissman JD.
    Mod Pathol; 1989 Nov; 2(6):569-76. PubMed ID: 2479944
    [Abstract] [Full Text] [Related]

  • 4. Myoepithelial cell cocktail (p63+SMA) for the evaluation of sclerosing breast lesions.
    Pavlakis K, Zoubouli C, Liakakos T, Messini I, Keramopoullos A, Athanassiadou S, Kafousi M, Stathopoulos EN.
    Breast; 2006 Dec; 15(6):705-12. PubMed ID: 16384708
    [Abstract] [Full Text] [Related]

  • 5. Ductal carcinoma in situ with spindle cells: a potential diagnostic pitfall in the evaluation of breast lesions.
    Tan PH, Lui GG, Chiang G, Yap WM, Poh WT, Bay BH.
    Histopathology; 2004 Oct; 45(4):343-51. PubMed ID: 15469472
    [Abstract] [Full Text] [Related]

  • 6. M34 actin regulatory protein is a sensitive diagnostic marker for early- and late-stage mammary carcinomas.
    Soriano Z, Pardee JD.
    Clin Cancer Res; 2004 Jul 01; 10(13):4437-43. PubMed ID: 15240534
    [Abstract] [Full Text] [Related]

  • 7. Benign myoepithelial tumors of the breast have immunophenotypic characteristics similar to metaplastic matrix-producing and spindle cell carcinomas.
    Popnikolov NK, Ayala AG, Graves K, Gatalica Z.
    Am J Clin Pathol; 2003 Aug 01; 120(2):161-7. PubMed ID: 12931544
    [Abstract] [Full Text] [Related]

  • 8. CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions.
    Barth PJ, Ebrahimsade S, Ramaswamy A, Moll R.
    Virchows Arch; 2002 Mar 01; 440(3):298-303. PubMed ID: 11889601
    [Abstract] [Full Text] [Related]

  • 9. The usefulness of p63 as a marker of breast myoepithelial cells.
    Batistatou A, Stefanou D, Arkoumani E, Agnantis NJ.
    In Vivo; 2003 Mar 01; 17(6):573-6. PubMed ID: 14758723
    [Abstract] [Full Text] [Related]

  • 10. Myoepithelial cell differentiation markers in prepubertal bovine mammary gland: effect of ovariectomy.
    Safayi S, Korn N, Bertram A, Akers RM, Capuco AV, Pratt SL, Ellis S.
    J Dairy Sci; 2012 Jun 01; 95(6):2965-76. PubMed ID: 22612934
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic significance of the immunoexpression of CD34 and smooth muscle cell actin in benign and malignant tumors of the breast.
    Cîmpean AM, Raica M, Nariţa D.
    Rom J Morphol Embryol; 2005 Jun 01; 46(2):123-9. PubMed ID: 16286998
    [Abstract] [Full Text] [Related]

  • 12. Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome.
    Iwaya K, Ogawa H, Izumi M, Kuroda M, Mukai K.
    Virchows Arch; 2002 Jun 01; 440(6):589-93. PubMed ID: 12070597
    [Abstract] [Full Text] [Related]

  • 13. Adenomyoepithelial tumours and myoepithelial carcinomas of the breast--a spectrum of monophasic and biphasic tumours dominated by immature myoepithelial cells.
    Hungermann D, Buerger H, Oehlschlegel C, Herbst H, Boecker W.
    BMC Cancer; 2005 Jul 28; 5():92. PubMed ID: 16050957
    [Abstract] [Full Text] [Related]

  • 14. CD10 Immunohistochemical Expression in Apocrine Lesions of the Breast.
    Kővári B, Báthori Á, Cserni G.
    Pathobiology; 2015 Jul 28; 82(6):259-63. PubMed ID: 26562027
    [Abstract] [Full Text] [Related]

  • 15. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.
    Rakha EA, Putti TC, Abd El-Rehim DM, Paish C, Green AR, Powe DG, Lee AH, Robertson JF, Ellis IO.
    J Pathol; 2006 Mar 28; 208(4):495-506. PubMed ID: 16429394
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical differentiation of atypical hyperplasia vs. carcinoma in situ of the breast.
    Masood S, Sim SJ, Lu L.
    Cancer Detect Prev; 1992 Mar 28; 16(4):225-35. PubMed ID: 1281040
    [Abstract] [Full Text] [Related]

  • 17. The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast.
    Tse GM, Tan PH, Lui PC, Gilks CB, Poon CS, Ma TK, Law BK, Lam WW.
    J Clin Pathol; 2007 Mar 28; 60(3):315-20. PubMed ID: 16698948
    [Abstract] [Full Text] [Related]

  • 18. High-grade carcinomas of the breast showing patterns of mixed ductal and myoepithelial differentiation (including myoepithelial cell-rich carcinoma of the breast).
    Coyne JD, Dervan PA, Barr L.
    Histopathology; 2004 Jun 28; 44(6):580-4. PubMed ID: 15186273
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Phenotypic alterations in myoepithelial cells associated with benign sclerosing lesions of the breast.
    Hilson JB, Schnitt SJ, Collins LC.
    Am J Surg Pathol; 2010 Jun 28; 34(6):896-900. PubMed ID: 20463570
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.